Skip to content

A Study to Find Out Whether the Homeopathic Medicine Folliculinum Can Reduce pre menstrual syndrome in Women Aged 15 35 Years

A Prospective Single arm study to evaluate the effectiveness of Folliculinum 30C in reducing premenstrual syndrome symptoms using PMMS in women aged 15 to 35 - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102343
Enrollment
75
Registered
2026-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N943- Premenstrual tension syndrome

Interventions

Intervention1: Folliculinum 30C: Folliculinum 30C will be administered in single dose 4 pills orally given 1 week before menses on empty stomach for a period of 4 months Control Intervention1: Placebo

Sponsors

JIMS HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants clinically diagnosed as per ACOG criteria premenstrual symptoms not linked to any organic lesions typically occur during the luteal phase of ovulatory cycles and resolve afterward must be severe enough to impact daily life or require medical attention, they may be classified as Premenstrual Dysphoric Disorder PMDD between the age group 15 to 35 years having Regular Menses for past 6 months presenting with a Pelvic USG scan finding of within normal pelvic pathology for female reproductive organs

Exclusion criteria

Exclusion criteria: Participants presenting with organic pelvic lesions or irregular menstrual cycles as well as those with psychiatric comorbidities such as depression or anxiety requiring pharmacological treatment were excluded from the study Individuals currently undergoing hormonal therapy were also not considered eligible Additionally participants with thyroid disorders or other systemic conditions including fibroids PCOD or cysts in the uterus or ovaries were excluded Those already receiving complementary and alternative medicine (CAM) therapies were also not included in the study sample

Design outcomes

Primary

MeasureTime frame
To Evaluate the effectiveness of Folliculinum 30 C in reducing the PMS Scale for a period of 4 monthsTimepoint: Baseline second and fourth month

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Pindi Sowmya

JIMS Homoeopathic Medical College and Hospital

manayilanjali@gmail.com8075354494

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026